|
| ![]() |
![]() | 07-10-08 癌症治疗的新观点 | 07-04-11 Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and V | 07-04-10 Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor R | 07-04-10 Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With C | 07-04-10 Randomized Phase III Trial of Whole-Abdominal Irradiation Versus Doxorubicin and Cisplatin Chemotherapy in Advanced Endometrial Ca | 07-04-10 Comparison of CA-125 and Standard Definitions of Progression of Ovarian Cancer in the Intergroup Trial of Cisplatin and Paclitaxel | 07-04-10 Hormone Replacement Therapy Is Associated With Decreased Survival in Women With Lung Cancer | 07-04-10 Early Identification of Resistance to First-Line Single-Agent Methotrexate in Patients With Persistent Trophoblastic Disease | 07-04-10 First-Line Single Agent Treatment With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer: A Phase II Study | 07-04-10 Early Identification of Resistance to First-Line Single-Agent Methotrexate in Patients With Persistent Trophoblastic Disease | 07-04-10 Neuroendocrine Neoplasms of the Lung: A Prognostic Spectrum | 07-04-10 Patterns of Care in Early-Stage Breast Cancer Survivors in the First Year After Cessation of Active Treatment | 07-04-10 Factors Related to Underuse of Surveillance Mammography Among Breast Cancer Survivors | 07-04-10 Psychological Distress in Men With Breast Cancer | 07-04-10 Successful Chemotherapeutic Modality of Doxorubicin Plus Dacarbazine for the Treatment of Desmoid Tumors in Association With Famil | 07-04-10 Phase III Study of Efaproxiral As an Adjunct to Whole-Brain Radiation Therapy for Brain Metastases | 07-04-10 Salvage Radioimmunotherapy With Murine Iodine-131–Labeled Antitenascin Monoclonal Antibody 81C6 for Patients With Recurrent Primar | 07-04-10 Low Value of [18F]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Primary Staging of Early-Stage Cervical Cancer Before | 07-04-10 Preliminary Results on Safety and Activity of a Randomized, Double-Blind, 2 x 2 Trial of Low-Dose Tamoxifen and Fenretinide for Br | 07-04-10 Unconventional Anticancer Agents: A Systematic Review of Clinical Trials | 07-04-10 Impact of the Year 2000 Medicare Policy Change on Older Patient Enrollment to Cancer Clinical Trials | 07-04-10 Comparable Long-Term Survival After Unrelated and HLA-Matched Sibling Donor Hematopoietic Stem Cell Transplantations for Acute Leu | 07-04-10 Intensive Therapy With Growth Factor Support for Patients With Ewing Tumor Metastatic at Diagnosis: Pediatric Oncology Group/Child | 07-04-10 Decision Making in Pediatric Oncology: Who Should Take the Lead The Decisional Priority in Pediatric Oncology Model | 07-04-10 Clinical Experience With Intravenous and Oral Formulations of the Novel Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic A | 07-04-10 Phase II Study of Oral Fludarabine Phosphate in Relapsed Indolent B-Cell Non-Hodgkin's Lymphoma | 07-04-10 Radiotherapy As Primary Treatment for Stage IE and IIE Nasal Natural Killer/T-Cell Lymphoma | 07-04-10 Clinical Cancer Advances 2005: Major Research Advances in Cancer Treatment, Prevention, and Screening—A Report From the American S | 07-04-10 Impact of Vascular Endothelial Growth Factor-A Expression, Thrombospondin-2 Expression, and Microvessel Density on the Treatment E | 07-04-10 Vascular Endothelial Growth Factor-D and Its Receptor VEGFR-3: Two Novel Independent Prognostic Markers in Gastric Adenocarcinoma | 07-04-10 Multipopulation Analysis of Polymorphisms in Five Mononucleotide Repeats Used to Determine the Microsatellite Instability Status o | 07-04-10 New MUC1 Serum Immunoassay Differentiates Pancreatic Cancer From Pancreatitis | 07-04-10 Gene Expression Profiling of Localized Esophageal Carcinomas: Association With Pathologic Response to Preoperative Chemoradiation | 07-04-10 EZH2 Expression Is Associated With High Proliferation Rate and Aggressive Tumor Subgroups in Cutaneous Melanoma and Cancers of the | 07-04-10 Tumor Necrosis Factor-–Induced Protein 3 As a Putative Regulator of Nuclear Factor-B–Mediated Resistance to O6-Alkylating Agents i | 07-04-10 High Frequency of Submicroscopic Hemizygous Deletion Is a Major Mechanism of Loss of Expression of PTEN in Uveal Melanoma | 07-04-10 Array-Based Comparative Genomic Hybridization Analysis Reveals Recurrent Chromosomal Alterations and Prognostic Parameters in Prim | 07-04-10 Evaluation of Two Phosphorylation Sites Improves the Prognostic Significance of Akt Activation in Non–Small-Cell Lung Cancer Tumor | 07-04-10 Prognostic Significance of Chromosome Aberrations in High-Grade Soft Tissue Sarcomas | 07-04-10 Randomized Trial Comparing Axillary Clearance Versus No Axillary Clearance in Older Patients With Breast Cancer: First Results of | 07-04-10 Correlates of Return to Work for Breast Cancer Survivors | 07-04-10 Assessing BRCA Carrier Probabilities in Extended Families | 07-04-10 The Use of Radiation As a Component of Breast Conservation Therapy in National Comprehensive Cancer Network Centers | 07-04-10 Multicycle Dose-Intensive Chemotherapy for Women With High-Risk Primary Breast Cancer: Results of International Breast Cancer Stud | 07-04-10 Phase II Study of Fixed Dose Rate Gemcitabine With Cisplatin for Metastatic Adenocarcinoma of the Pancreas | 07-04-10 Postoperative Surveillance in Patients With Colorectal Cancer Who Have Undergone Curative Resection: A Prospective, Multicenter, R | 07-04-10 OPTIMOX1: A Randomized Study of FOLFOX4 or FOLFOX7 With Oxaliplatin in a Stop-and-Go Fashion in Advanced Colorectal Cancer—A GERCO | 07-04-10 Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors | 07-04-10 Similar Outcomes Between African American and Non–African American Patients With Extensive-Stage Small-Cell Lung Carcinoma: Report | 07-04-10 The Effect of Race on Invasive Staging and Surgery in Non–Small-Cell Lung Cancer | 07-04-10 Astragalus-Based Chinese Herbs and Platinum-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Meta-Analysis of Randomize | 07-04-10 Phase III Clinical Trial of Thalidomide Plus Dexamethasone Compared With Dexamethasone Alone in Newly Diagnosed Multiple Myeloma: | 07-04-10 Select High-Risk Genetic Features Predict Earlier Progression Following Chemoimmunotherapy With Fludarabine and Rituximab in Chron | 07-04-10 Treatment for Acute Myelogenous Leukemia by Low-Dose, Total-Body, Irradiation-Based Conditioning and Hematopoietic Cell Transplant | 07-04-10 High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positiv | 07-04-10 Comparison Between Patients With Philadelphia-Positive Chronic Phase Chronic Myeloid Leukemia Who Obtained a Complete Cytogenetic | 07-04-10 Long-Term Risk of Cardiovascular Disease in 5-Year Survivors of Testicular Cancer | 07-04-10 Risk of Selected Subsequent Carcinomas in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study | 07-04-10 Thromboembolism in Hospitalized Neutropenic Cancer Patients | 07-04-10 Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Re |
| ![]() | ![]() |
癌症治疗(15篇,2007.10.08) 癌变·畸变·突变 2000年(3篇,2003.08.07) 2001年(1篇,2003.08.07) 癌症进展(2篇,2005.09.28) 癌症康复(6篇,2004.08.29) 白血病·淋巴瘤 2003年(4篇,2003.08.24) 癌症 1998年(11篇,2005.07.03) 1999年(405篇,2005.07.04) 2000年(226篇,2005.07.04) 2003年(28篇,2004.06.26) 2004年(27篇,2004.06.26) 中德临床肿瘤学杂志(英文版) 1999年(57篇,2005.07.03) 2000年(137篇,2005.07.03) 国际肿瘤学杂志(11篇,2004.11.14) 肿瘤基础与临床 2002年(17篇,2004.06.23) 临床肿瘤学杂志 2002年(94篇,2004.11.13) 2003年(1篇,2003.08.07) 2006年(110篇,2007.04.11) 肿瘤防治杂志 2000年(125篇,2004.11.14) 2002年(1篇,2003.08.07) 实用肿瘤杂志 2002年(116篇,2004.11.13) 2003年(28篇,2004.06.26) 2004年(31篇,2004.06.26) 中国癌症杂志 1999年(1篇,2004.11.13) 中国肺癌杂志 2000年(237篇,2005.07.06) 2002年(2篇,2003.08.07) 中国肿瘤临床 1999年(13篇,2004.11.14) 2000年(253篇,2005.07.04) 2003年(3篇,2004.06.24) 中国肿瘤临床与康复 2000年(115篇,2003.09.01) 2002年(316篇,2005.07.02) 中国肿瘤生物治疗杂志 2000年(101篇,2004.11.13) 中国肿瘤 2000年(1篇,2003.08.07) 2001年(431篇,2005.05.03) 2002年(450篇,2005.05.03) 2003年(275篇,2005.05.03) 2004年(311篇,2005.12.18) 2005年(205篇,2005.12.18) 中华放射肿瘤学杂志 1999年(130篇,2004.11.13) 2000年(133篇,2005.07.04) 2002年(82篇,2005.07.03) 中华肿瘤杂志 1998年(171篇,2005.07.06) 1999年(146篇,2005.07.06) 2000年(223篇,2005.07.06) 2002年(382篇,2005.07.03) 2003年(106篇,2005.07.03) 中华肿瘤防治杂志 1998年(130篇,2005.07.03) 1999年(71篇,2005.07.03) 肿瘤 1999年(215篇,2005.07.03) 2000年(110篇,2005.07.03) 2004年(1篇,2004.06.26) 肿瘤防治研究 2002年(123篇,2004.11.13) 肿瘤学杂志 2001年(172篇,2005.05.03) 2002年(179篇,2005.05.03) 2003年(161篇,2005.05.03) 2004年(190篇,2005.12.18) 2005年(145篇,2005.12.18) 肿瘤学学报 2006年(23篇,2006.07.22) 肿瘤学家 2006年(49篇,2006.07.13)
|
|